Contact this trialFirst, we need to learn more about you.
Cendakimab for Healthy Subjects
Recruiting1 awardPhase 1
Anaheim, California
This trial aims to study how cendakimab, given as an injection under the skin, behaves in healthy people. The goal is to understand the drug's levels in the body without any interference from diseases. Cendakimab works by blocking proteins that cause inflammation.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service